822 related articles for article (PubMed ID: 15531889)
1. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.
Kong W; Wei J; Abidi P; Lin M; Inaba S; Li C; Wang Y; Wang Z; Si S; Pan H; Wang S; Wu J; Wang Y; Li Z; Liu J; Jiang JD
Nat Med; 2004 Dec; 10(12):1344-51. PubMed ID: 15531889
[TBL] [Abstract][Full Text] [Related]
2. Combination of simvastatin with berberine improves the lipid-lowering efficacy.
Kong WJ; Wei J; Zuo ZY; Wang YM; Song DQ; You XF; Zhao LX; Pan HN; Jiang JD
Metabolism; 2008 Aug; 57(8):1029-37. PubMed ID: 18640378
[TBL] [Abstract][Full Text] [Related]
3. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine.
Abidi P; Zhou Y; Jiang JD; Liu J
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2170-6. PubMed ID: 16100034
[TBL] [Abstract][Full Text] [Related]
4. SCAP ligands are potent new lipid-lowering drugs.
Grand-Perret T; Bouillot A; Perrot A; Commans S; Walker M; Issandou M
Nat Med; 2001 Dec; 7(12):1332-8. PubMed ID: 11726974
[TBL] [Abstract][Full Text] [Related]
5. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.
Pirillo A; Catapano AL
Atherosclerosis; 2015 Dec; 243(2):449-61. PubMed ID: 26520899
[TBL] [Abstract][Full Text] [Related]
6. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
[TBL] [Abstract][Full Text] [Related]
7. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.
Zhou Y; Cao S; Wang Y; Xu P; Yan J; Bin W; Qiu F; Kang N
Fitoterapia; 2014 Jan; 92():230-7. PubMed ID: 24321576
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of berberine analogues as a novel class of low-density-lipoprotein receptor up-regulators.
Yang P; Song DQ; Li YH; Kong WJ; Wang YX; Gao LM; Liu SY; Cao RQ; Jiang JD
Bioorg Med Chem Lett; 2008 Aug; 18(16):4675-7. PubMed ID: 18644725
[TBL] [Abstract][Full Text] [Related]
9. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway.
Huang C; Zhang Y; Gong Z; Sheng X; Li Z; Zhang W; Qin Y
Biochem Biophys Res Commun; 2006 Sep; 348(2):571-8. PubMed ID: 16890192
[TBL] [Abstract][Full Text] [Related]
10. Berberine decreases plasma triglyceride levels and upregulates hepatic TRIB1 in LDLR wild type mice and in LDLR deficient mice.
Singh AB; Liu J
Sci Rep; 2019 Oct; 9(1):15641. PubMed ID: 31666640
[TBL] [Abstract][Full Text] [Related]
11. Berberine--a novel approach to cholesterol lowering.
Doggrell SA
Expert Opin Investig Drugs; 2005 May; 14(5):683-5. PubMed ID: 15926873
[TBL] [Abstract][Full Text] [Related]
12. Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy.
Li YH; Yang P; Kong WJ; Wang YX; Hu CQ; Zuo ZY; Wang YM; Gao H; Gao LM; Feng YC; Du NN; Liu Y; Song DQ; Jiang JD
J Med Chem; 2009 Jan; 52(2):492-501. PubMed ID: 19090767
[TBL] [Abstract][Full Text] [Related]
13. Analysis of polymorphisms in the 3' untranslated region of the LDL receptor gene and their effect on plasma cholesterol levels and drug response.
Chen W; Wang S; Ma Y; Zhou Y; Liu H; Strnad P; Kraemer FB; Krauss RM; Liu J
Int J Mol Med; 2008 Mar; 21(3):345-53. PubMed ID: 18288382
[TBL] [Abstract][Full Text] [Related]
14. Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters.
Li XY; Zhao ZX; Huang M; Feng R; He CY; Ma C; Luo SH; Fu J; Wen BY; Ren L; Shou JW; Guo F; Chen Y; Gao X; Wang Y; Jiang JD
J Transl Med; 2015 Aug; 13():278. PubMed ID: 26310319
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor.
Wang YX; Wang YP; Zhang H; Kong WJ; Li YH; Liu F; Gao RM; Liu T; Jiang JD; Song DQ
Bioorg Med Chem Lett; 2009 Nov; 19(21):6004-8. PubMed ID: 19800225
[TBL] [Abstract][Full Text] [Related]
16. Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells.
Holy EW; Akhmedov A; Lüscher TF; Tanner FC
J Mol Cell Cardiol; 2009 Feb; 46(2):234-40. PubMed ID: 19014947
[TBL] [Abstract][Full Text] [Related]
17. Gossypin up-regulates LDL receptor through activation of ERK pathway: a signaling mechanism for the hypocholesterolemic effect.
Lu N; Li Y; Qin H; Zhang YL; Sun CH
J Agric Food Chem; 2008 Dec; 56(23):11526-32. PubMed ID: 19007237
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
[TBL] [Abstract][Full Text] [Related]
19. Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters.
Wang Y; Jia X; Ghanam K; Beaurepaire C; Zidichouski J; Miller L
Atherosclerosis; 2010 Mar; 209(1):111-7. PubMed ID: 19782362
[TBL] [Abstract][Full Text] [Related]
20. The critical role of mRNA destabilizing protein heterogeneous nuclear ribonucleoprotein d in 3' untranslated region-mediated decay of low-density lipoprotein receptor mRNA in liver tissue.
Singh AB; Li H; Kan CF; Dong B; Nicolls MR; Liu J
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):8-16. PubMed ID: 24158514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]